A detailed history of Commonwealth Equity Services, LLC transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Commonwealth Equity Services, LLC holds 19,513 shares of HALO stock, worth $956,137. This represents 0.0% of its overall portfolio holdings.

Number of Shares
19,513
Previous 20,382 4.26%
Holding current value
$956,137
Previous $1.07 Million 4.69%
% of portfolio
0.0%
Previous 0.0%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

SELL
$51.3 - $64.42 $44,579 - $55,980
-869 Reduced 4.26%
19,513 $1.12 Million
Q2 2024

Jul 31, 2024

BUY
$37.81 - $52.4 $196,990 - $273,004
5,210 Added 34.34%
20,382 $1.07 Million
Q1 2024

Apr 29, 2024

SELL
$33.68 - $41.95 $53,416 - $66,532
-1,586 Reduced 9.46%
15,172 $617,000
Q4 2023

Feb 06, 2024

BUY
$33.32 - $42.1 $18,059 - $22,818
542 Added 3.34%
16,758 $619,000
Q3 2023

Oct 23, 2023

BUY
$36.46 - $44.03 $12,651 - $15,278
347 Added 2.19%
16,216 $619,000
Q2 2023

Aug 10, 2023

BUY
$30.28 - $38.74 $16,684 - $21,345
551 Added 3.6%
15,869 $572,000
Q1 2023

May 11, 2023

SELL
$32.86 - $55.7 $233,536 - $395,859
-7,107 Reduced 31.69%
15,318 $584,000
Q4 2022

Feb 07, 2023

SELL
$40.06 - $59.44 $196,173 - $291,077
-4,897 Reduced 17.92%
22,425 $1.28 Million
Q3 2022

Nov 14, 2022

BUY
$38.53 - $51.78 $1,965 - $2,640
51 Added 0.19%
27,322 $1.08 Million
Q2 2022

Jul 19, 2022

BUY
$37.35 - $48.3 $290,470 - $375,629
7,777 Added 39.89%
27,271 $1.2 Million
Q4 2021

Jan 31, 2022

BUY
$31.82 - $40.75 $37,229 - $47,677
1,170 Added 6.39%
19,494 $783,000
Q3 2021

Oct 29, 2021

SELL
$38.47 - $46.42 $24,389 - $29,430
-634 Reduced 3.34%
18,324 $745,000
Q2 2021

Aug 11, 2021

SELL
$38.84 - $51.31 $123,122 - $162,652
-3,170 Reduced 14.33%
18,958 $860,000
Q1 2021

May 04, 2021

BUY
$39.51 - $51.45 $3,792 - $4,939
96 Added 0.44%
22,128 $922,000
Q4 2020

Feb 11, 2021

SELL
$25.81 - $43.62 $192,361 - $325,099
-7,453 Reduced 25.28%
22,032 $940,000
Q3 2020

Nov 05, 2020

SELL
$25.74 - $29.63 $1,287 - $1,481
-50 Reduced 0.17%
29,485 $774,000
Q2 2020

Aug 12, 2020

SELL
$16.25 - $26.81 $32,500 - $53,620
-2,000 Reduced 6.34%
29,535 $791,000
Q1 2020

May 11, 2020

SELL
$13.9 - $21.83 $2,224 - $3,492
-160 Reduced 0.5%
31,535 $567,000
Q4 2019

Feb 05, 2020

SELL
$14.93 - $19.53 $197,001 - $257,698
-13,195 Reduced 29.39%
31,695 $561,000
Q2 2019

Jul 19, 2019

BUY
$14.75 - $17.26 $15,487 - $18,123
1,050 Added 2.4%
44,890 $771,000
Q1 2019

May 13, 2019

BUY
$13.94 - $17.58 $1,533 - $1,933
110 Added 0.25%
43,840 $705,000
Q4 2018

Feb 11, 2019

SELL
$13.33 - $18.66 $1.83 Million - $2.56 Million
-137,378 Reduced 75.85%
43,730 $639,000
Q3 2018

Nov 06, 2018

BUY
$16.68 - $18.41 $1.21 Million - $1.33 Million
72,279 Added 66.42%
181,108 $3.29 Million
Q2 2018

Jul 31, 2018

BUY
$16.87 - $20.3 $35,427 - $42,630
2,100 Added 1.97%
108,829 $1.84 Million
Q1 2018

May 14, 2018

BUY
$17.06 - $21.2 $60,614 - $75,323
3,553 Added 3.44%
106,729 $2.09 Million
Q4 2017

Feb 12, 2018

BUY
$16.75 - $20.8 $1.73 Million - $2.15 Million
103,176
103,176 $2.09 Million

Others Institutions Holding HALO

About HALOZYME THERAPEUTICS, INC.


  • Ticker HALO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 139,288,992
  • Market Cap $6.83B
  • Description
  • Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...
More about HALO
Track This Portfolio

Track Commonwealth Equity Services, LLC Portfolio

Follow Commonwealth Equity Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Commonwealth Equity Services, LLC with notifications on news.